GLP-1 agonists for heart failure: most comprehensive evidence to date of benefit Heart failure patients could be the next group to benefit from GLP-1 agonists, which are currently approved for the treatment of diabetes and obesity
Because these drugs affect the nervous system, understanding their mechanisms and potential interactions is important before combining them
In that case, its a good idea to consult with your GP, pharmacist, or healthcare expert first
Behavioral therapies, such as cognitive-behavioral therapy, can also be helpful in addressing the underlying psychological issues that may contribute to addiction
ArticlePubMed 51
Scot Simpson, who teaches at the Faculty of Pharmacy for the University of Alberta, as to how it became such a popular drug of choice